Philipp C. Münch

Jim Cramer Now Jim Cramer warns against trading Nvidia after blowout quarter CNBC - Julie Coleman • 57m CNBC's Jim Cramer on Thursday said he thinks it's unwise to trade Nvidia, saying investors should keep the AI darling. "Until the AI revolution runs … Technology Now Analysts revise First Solar stock price target on AI angle TheStreet - Rob Lenihan • 28m Here's what could happen next to First Solar shares.

Abstract The success of deep learning in various applications depends on task-specific architecture design choices, including the types, hyperparameters, and number of layers. In computational biology, there is no consensus on the optimal architecture design, and decisions are often made using insights from more well-established fields such as computer vision. These may not consider the domain-specific characteristics of genome sequences, potentially limiting performance.

Abstract Deep learning in bioinformatics is often limited to problems where extensive amounts of labeled data are available for supervised classification. By exploiting unlabeled data, self-supervised learning techniques can improve the performance of machine learning models in the presence of limited labeled data. Although many self-supervised learning methods have been suggested before, they have failed to exploit the unique characteristics of genomic data.